Applied dna reports third quarter fiscal 2025 financial results

Stony brook, ny / access newswire / august 14, 2025 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, today reported financial results for its third quarter of fiscal 2025 ended june 30, 2025. the company's form 10-q for its fiscal third quarter can be viewed on the sec filings page of its investor relations website.
APDN Ratings Summary
APDN Quant Ranking